About
Bio
Impact Factor:
Not presently indexed
Journal Ranking:
Not presently indexed
Frequency:
Bi monthly
Aims of the journal:
Tumours of the central nervous system (CNS) are the sixth most common form of cancer in adults and the most common form of solid cancer in children in the USA. Mortality rates remain high - primary CNS tumours are the second and fourth leading cause of cancer mortality in people under the ages of 34 and 54 years, respectively. Unfortunately, the prognosis for patients with malignant gliomas (the most common form of primary brain tumour) is largely unchanged from two decades ago, with survival being less than a year from diagnosis. Consequently, there is an urgent need to both develop effective new treatments and further the understanding of the biology for tumours arising in the CNS.
CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analysed by international experts, and the importance of the most recent advances in molecular biology are explained.
Content:
CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centred clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic.
The journal presents this information using a clear and accessible presentation style. All articles are subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
Email
email@cision.one
Website
site@cision.one
Social media
Location
United Kingdom
Frequency
upgrade
Circulation
upgrade
Sectors
Oncology
Bio
Impact Factor: Not presently indexed Journal Ranking: Not presently indexed Frequency: Bi monthly Aims of the journal: Tumours of the central nervous system (CNS) are the sixth most common form of cancer in adults and the most common form of solid cancer in children in the USA. Mortality rates remain high - primary CNS tumours are the second and fourth leading cause of cancer mortality in people under the ages of 34 and 54 years, respectively. Unfortunately, the prognosis for patients with malignant gliomas (the most common form of primary brain tumour) is largely unchanged from two decades ago, with survival being less than a year from diagnosis. Consequently, there is an urgent need to both develop effective new treatments and further the understanding of the biology for tumours arising in the CNS. CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analysed by international experts, and the importance of the most recent advances in molecular biology are explained. Content: CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centred clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic. The journal presents this information using a clear and accessible presentation style. All articles are subject to independent review by a minimum of three independent experts. Unsolicited article proposals are welcomed and authors are required to comply fully with the journal's Disclosure & Conflict of Interest Policy as well as major publishing guidelines, including ICMJE and GPP3.
Website
Social media
Location
Frequency
Circulation
Sectors
Oncology
Most recent articles by CNS Oncology
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Lorem ipsum dolor sit amet, consectetur adipiscing elit
Article description
Explore outlets similar to CNS Oncology
-
OOncologyLive
Established in 2000 as Oncology Net Guide and rebranded in March 2011 as OncLive. Written for physicians to enable them to keep up to date with the rapidly expanding amount of medical information and resources on oncology. Designed as a handbook for frequent referencing and written in an easy-to-understand style. Articles are quick-reading, timely, provides practical information and information about new medical treatments. Media Alert: Tuesday April 12th 2011 Oncology Net Guide has changed its name to OncLive. Anita Shaffer is Associate Editor in charge of the oncology research and technology magazine. She may be reached at +1 (609) 716 7777 Ext 192 and ashaffer@onclive.com
ViewTTargeted OncologyTargeted Oncology is an online resource for oncology news and research, carrying content from Intellisphere's printed oncology journals, Targeted Therapies and The Journal of Targeted Therapies.
ViewMMedical News TodayBackground and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.
ViewJJAMA OncologySet to launch in February 2015, this medical journal aimed at physicians covers oncology. Will feature all aspects of medical, radiation, and surgical oncology and its subspecialties
ViewTThe Lancet OncologyImpact Factor: 26.509 (Source:Thomson Reuters Journal Citation 2016) Format and Background: The Lancet Oncology publishes interesting and informative reviews on any topic connected with oncology, and considers any original research contribution that advocates change in, or illuminates, oncological clinical practice. Circulation: The Publisher does not disclose the circulation. Aims of the journal: The Lancet Oncology was launched in September 2000 with the aim of being a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. In May 2005, the journal expanded to include original research and began publishing articles online first prior to print publication. In 2008, the journal expanded its online presence to include regular podcasts. The aim of The Lancet Oncology is to publish interesting, informative, and practice-changing articles on any topic connected with clinical oncology. Readership: Clinical cancer specialists worldwide. Content: Topics include, but are not limited to: Breast cancer Endocrine system cancer Gastrointestinal cancer Genitourinary cancer Gynaecological cancer Haematological cancer Head and neck cancer Neurooncology Paediatric oncology Thoracic oncology Sarcoma Skin cancer Epidemiology, cancer prevention, and cancer control Supportive care Imaging Health-care systems Manuscript submission: The journal publishes a range of article types that encompass all aspects of oncological medicine: Comment, Correspondence, News, Cancer and Society, Article, Meta-analysis, Review, Historical Review, Health-care Development, Personal View, and Debate. For further information for authors, click here. Online manuscripts submission here. Ad Rates: Can be viewed here the advertising team can be reached at lancet-ads@elsevier.com Other Information: The RSS feed can be viewed here Podcasts can be found here Information for the press can be viewed here
ViewUse CisionOne to find more relevant outletsExplore journalists that write for CNS Oncology
-
L
Contact us to find more relevant journalistsDiscover the stories that impact your brand. In realtime.
CisionOne delivers relevant news, trends and conversations that matter to your brand with the world’s most comprehensive media monitoring service across Print, Online, TV, Radio, Social, Magazines, Podcasts and more.
